hyalgan.com Report : Visit Site

Technical data of the hyalgan.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host hyalgan.com. Currently, hosted in United States and its service provider is Liquid Web Inc. .

the related websites

kneepaincenterdfw.com biomedcentral.com cameronmedical.com thekneedoc.co.uk durolane.com northeastpainmanagement.com dnslondon.co.uk expanscience.com becta.org.uk wokingham.gov.uk nptc.org de.bosch-automotive.com toolbank.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.2.34 (Unix) mod_ssl/2.2.34 OpenSSL/1.0.1e-fips mod_bwlimited/1.4 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

references altman rd, moskowitz r; ® study group. intraarticular sodium hyaluronate (®) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. j rheumatol. 1998;25(11):2203-2212. hammesfahr jfr, knopf ab, stitik t. safety of intra-articular hyaluronates for pain associated with osteoarthritis of the knee. am j orthop. 2003;32(6):277-283. kelly ma, goldberg vm, healy wl, pagnano mw, hamburger mi. osteoarthritis and beyond: a consensus on the past, present, and future of hyaluronans in orthopedics. orthopedics. 2003;26(10):1064-1079. ®, data on file. fidia farmaceutici s.p.a., italy. ® (sodium hyaluronate), approval letter. food and drug administration web site. http://www.accessdata.fda.gov/cdrh_docs/pdf/p950027a.pdf. accessed august 18, 2011. carrabba m, paresce e, angelini m, re ka, torchiana eem, perbellini a. the safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. eur j rheumatol inflamm. 1995;15(1):25-31. bragantini a, cassini m, de bastiani g, perbellini a. controlled single-blind trial of intra-articularly injected hyaluronic acid (®) in osteo-arthritis of the knee. clin trials j. 1987;24(4):333-340. grecomoro g, martorana u, di marco c. intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. pharmatherapeutica. 1987;5(2):137-141. scali jj. intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: a long term study. eur j rheumatol inflamm. 1995;15(1):57-62. ghosh p, guidolin d. potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular-weight dependent? semin arthritis rheum. 2002;32(1):10-37. balazs e. the physical properties of synovial fluid and the specific role of hyaluronic acid. in: helfet aj, ed. disorders of the knee. 2nd ed. philadelphia, pa: jb lippincott; 1982:61-74. gotoh s, miyazaki k, onaya j, sakamoto t, tokuyasu t, namiki o. experimental knee pain model in rats and analgesic effect of sodium hyaluronate (sph) [in japanese]. nippon yakurigaku zasshi. 1988;92(1):17-27. pozo ma, balazs ea, belmonte c. reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative. exp brain res. 1997;116:3-9. ®. [package insert]. abano terme, italy: fidia farmaceutici; may 2014 neustadt dh. long-term efficacy and safety of intra-articular sodium hyaluronate (®) in patients with osteoarthritis of the knee. clin exp rheumatol. 2003;21(3):307-311. stitik tp et al. arch phys med rehabil. 2007;88(2):135-141 turajane t, labpiboonpong v, maungsiri s. cost analysis of intraarticular sodium hyaluronate treatment in knee osteoarthritis patients who failed conservative treatment. j med assoc thai. 2007;90(9):1839-1844. parmet s, lynm c, glass rm. osteoarthritis of the knee. jama. 2003;289(8):1068. -- this site is intended for us consumers healthcare professionals important safety information prescription information -- why ® benefits of ® clinical data quick facts faq about osteoarthritis signs and symptoms how does osteoarthritis damage the knee? treatment living with osteoarthritis knee exercises general tips useful links support patients why benefits of quick facts faq about osteoarthritis signs and symptoms how does osteoarthritis damage the knee? treatment living with osteoarthritis knee exercises general tips useful links support healthcare professionals prescription information pain relief for osteoarthritis (oa) of the knee. ® is a proven treatment that relieves oa knee pain for people just like you. 1 learn more about osteoarthritis patient support search the faqs about osteoarthritis patient support search the faqs tips for living with osteoarthritis -- indication ® is indicated for the treatment of pain in osteoarthritis (oa) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, eg, acetaminophen. important safety information is contraindicated in patients with known hypersensitivity to hyaluronate preparations or in cases of present infections or skin diseases in the area of the injection site. use caution when injecting into patients who are allergic to avian proteins, feathers, and egg products. the safety and effectiveness of has not been established in children or in pregnant or lactating women, for use in other joints or for concomitant use with other injectables. it is unknown whether ® is excreted in human milk. the effectiveness of a single treatment cycle of less than 3 injections has not been established. transient increases in inflammation in the injected knee following injection have been reported in some patients with inflammatory arthritis and should not be injected if objective signs of inflammation are present. transient pain and/or swelling of the injected joint may occur after intra-articular injection of ®. anaphylactoid and allergic reactions have been reported with the use of this product. in the us clinical trial, adverse events included injection-site pain, gastrointestinal complaints, headache, local ecchymosis (bruising) and rash, local joint pain and swelling, and local pruritus (itching). in other clinical studies, the frequency and severity of adverse events occurring during repeat treatment cycles did not increase over that reported for a treatment cycle. rx only. see the package insert section of this website for full prescribing information. 1-866-7- references legal disclaimer privacy policy why ® healthcare professionals website fidia farmaceutici s.p.a. © 2018 fidia pharma usa inc, florham park, nj 07932 this site is intended for use by us residents only. last update: july 2018 are you sure you want to navigate away from this page? click ok to continue on to the fidia corporate site or cancel to stay on current page. cancel continue you are about to leave .com the recommended links are for third party organizations. fidia is not responsible for the content and is not providing any endorsement of the website. cancel continue

URL analysis for hyalgan.com

http://hyalgan.com/patients/about-osteoarthritis/treatment/
http://hyalgan.com/patients/living-with-osteoarthritis/
http://hyalgan.com/patients/support/
http://hyalgan.com/wp-content/uploads/2016/05/hyalganpatinfopdfupdate513.pdf
http://hyalgan.com/patients/living-with-osteoarthritis/knee-exercises/
http://hyalgan.com/patients/why-hyalgan/clinical-data/
http://hyalgan.com/patients/why-hyalgan/benefits-of-hyalgan/
http://hyalgan.com/hcp/
http://hyalgan.com/#mobilenav
http://hyalgan.com/patients/why-hyalgan/faq/
http://hyalgan.com/hcp/references/#ref-1
http://hyalgan.com/patients/about-osteoarthritis/
http://hyalgan.com/#references
http://hyalgan.com/wp-content/themes/nebula-master/pdf/hyalgan_pi.pdf
http://hyalgan.com/#important-safety-information

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: HYALGAN.COM
Registry Domain ID: 1570136_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.register.it
Registrar URL: http://www.register.it
Updated Date: 2017-07-12T07:03:59Z
Creation Date: 1998-07-12T04:00:00Z
Registry Expiry Date: 2018-07-11T04:00:00Z
Registrar: Register.it SPA
Registrar IANA ID: 168
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +39.5520021555
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.REGISTER.IT
Name Server: NS2.REGISTER.IT
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-07-26T20:09:54Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Register.it SPA

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =hyalgan.com

  PORT 43

  TYPE domain

DOMAIN

  NAME hyalgan.com

  CHANGED 2017-07-12

  CREATED 1998-07-12

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

NSERVER

  NS1.REGISTER.IT 195.110.124.140

  NS2.REGISTER.IT 195.7.227.1

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .